시장보고서

상품코드

1790378

미국의 괴사조직 제거 시장 규모·점유율·동향 분석 리포트 : 제품 유형별, 방법별, 창상 유형별, 최종 용도별, 구입 형태별, 부문 예측(2025-2033년)

U.S. Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes), By Method, By Wound Type, By End-use, By Mode of Purchase, And Segment Forecasts, 2025 - 2033

발행일: 2025년 07월 | 리서치사:

Grand View Research | 페이지 정보: 영문 80 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 괴사조직 제거 시장 개요

미국의 괴사조직 제거 시장 규모는 2024년에 15억 3,000만 달러, 2033년에는 22억 6,000만 달러에 달할 것으로 예측되며, 2025-2033년에 CAGR 4.3%로 성장합니다. 당뇨병, 비만, 외상 및 만성 상처 증가는 고급 상처 드레드맨 솔루션에 대한 수요를 지속적으로 견인하고 있습니다.

CDC에 따르면 약 1억 2,900만 명의 미국인이 적어도 한 가지 이상의 주요 만성질환을 앓고 있으며, 인구의 약 2%가 만성 상처를 앓고 있다고 합니다. 당뇨병성 족부 궤양, 욕창, 정맥 정체성 궤양과 같은 이러한 상처는 임상적으로 큰 문제를 야기하고, 치유 기간 연장, 합병증 위험 증가, 막대한 의료 자원의 소비와 관련이 있습니다.

규제와 혁신 측면에서 FDA와 같은 미국 연방 기관이 적극적으로 상황을 재구성하고 있습니다. FDA는 특정 상처 관리 제품(항균제를 포함한 젤, 크림, 연고, 액체 세정제)을 Class II 또는 III 기기로 재분류하여 510(k) 신고 및 시판 전 승인(PMA)을 통해 보다 엄격한 모니터링이 필요함을 제안했습니다.

The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% from 2025 to 2033. The increasing prevalence of diabetes, obesity, and the growing number of traumatic injuries and chronic wounds continue to drive demand for advanced wound debridement solutions.

According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.

On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).

U.S. Wound Debridement Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound debridement market report based on product, method, wound type, mode of purchase, and end use:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Gels
Ointments & Creams
Surgical Devices
Medical Gauzes
Ultrasonic Devices
Others
Method/Procedure Outlook (Revenue, USD Million, 2021 - 2033)
Autolytic
Enzymatic
Surgical
Mechanical
Others
Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
Pressure Ulcers
Diabetic Foot Ulcers
Venous Leg Ulcers
Burn Wound
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Homecare
Others
Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
Prescription
Over The Counter
Others

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.8. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Wound Debridement Market Variable Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. U.S. Wound Debridement Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitution
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal landscape
  - 3.3.2.2. Economic and Social landscape
  - 3.3.2.3. Technological landscape
  - 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework

Chapter 4. U.S. Wound Debridement Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Wound Debridement Market: Product Movement Analysis
4.3. U.S. Wound Debridement Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Gels
- 4.4.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Ointments & Creams
- 4.5.1. Ointments & Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Surgical Devices
- 4.6.1. Surgical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Medical Gauzes
- 4.7.1. Medical Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Ultrasonic Devices
- 4.8.1. Ultrasonic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Debridement Market: Method/Procedures Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Wound Debridement Market: Method/Procedures Movement Analysis
5.3. U.S. Wound Debridement Market Size & Trend Analysis, by Method/Procedures, 2021 to 2033 (USD Million)
5.4. Autolytic
- 5.4.1. Autolytic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Enzymatic
- 5.5.1. Enzymatic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Surgical
- 5.6.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Mechanical
- 5.7.1. Mechanical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Debridement Market: Wound Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. Wound Debridement Market: Wound Type Movement Analysis
6.3. U.S. Wound Debridement Market Size & Trend Analysis, by Wound Type, 2021 to 2033 (USD Million)
6.4. Pressure Ulcers
- 6.4.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Diabetic Foot Ulcers
- 6.5.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Venous Leg Ulcers
- 6.6.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Burn Wound
- 6.7.1. Burn Wound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Debridement Market: By End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. U.S. Wound Debridement Market: By End Use Movement Analysis
7.3. U.S. Wound Debridement Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
- 7.3.1. Hospitals
  - 7.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Homecare
  - 7.3.2.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Others
  - 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Debridement Market: By Mode of Purchase Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. U.S. Wound Debridement Market: By Mode of Purchase Movement Analysis
8.3. U.S. Wound Debridement Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
- 8.3.1. Prescription
  - 8.3.1.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Over the Counter
  - 8.3.2.1. Over the Counter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Others
  - 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
- 9.3.1. Zimmer Biomet
  - 9.3.1.1. Participant's Overview
  - 9.3.1.2. Financial Performance
  - 9.3.1.3. Product Benchmarking
  - 9.3.1.4. Strategic Initiatives
- 9.3.2. Smith+Nephew
  - 9.3.2.1. Participant's Overview
  - 9.3.2.2. Financial Performance
  - 9.3.2.3. Product Benchmarking
  - 9.3.2.4. Strategic Initiatives
- 9.3.3. Coloplast Group
  - 9.3.3.1. Participant's Overview
  - 9.3.3.2. Financial Performance
  - 9.3.3.3. Product Benchmarking
  - 9.3.3.4. Strategic Initiatives
- 9.3.4. Convatec Group PLC
  - 9.3.4.1. Participant's Overview
  - 9.3.4.2. Financial Performance
  - 9.3.4.3. Product Benchmarking
  - 9.3.4.4. Strategic Initiatives
- 9.3.5. C. R. Bard
  - 9.3.5.1. Participant's Overview
  - 9.3.5.2. Financial Performance
  - 9.3.5.3. Product Benchmarking
  - 9.3.5.4. Strategic Initiatives
- 9.3.6. Lohmann & Rauscher
  - 9.3.6.1. Participant's Overview
  - 9.3.6.2. Financial Performance
  - 9.3.6.3. Product Benchmarking
  - 9.3.6.4. Strategic Initiatives

미국의 괴사조직 제거 시장 규모·점유율·동향 분석 리포트 : 제품 유형별, 방법별, 창상 유형별, 최종 용도별, 구입 형태별, 부문 예측(2025-2033년)

U.S. Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes), By Method, By Wound Type, By End-use, By Mode of Purchase, And Segment Forecasts, 2025 - 2033

목차

제1장 조사 방법과 범위

제2장 개요

제3장 미국의 괴사조직 제거 시장의 변동 동향과 전망

제4장 미국의 괴사조직 제거 시장 : 제품별, 추정·동향 분석

제5장 미국의 괴사조직 제거 시장 : 방법별, 추정·동향 분석

제6장 미국의 괴사조직 제거 시장 : 창상 유형별, 추정·동향 분석

제7장 미국의 괴사조직 제거 시장 : 최종 용도별, 추정·동향 분석

제8장 미국의 괴사조직 제거 시장 : 구입 형태별, 추정·동향 분석

제9장 경쟁 구도

Table of Contents